Patent 11246875 was granted and assigned to TherapeuticsMD on February, 2022 by the United States Patent and Trademark Office.
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).